Clinical Trial Update: Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating Supraz and PRP-FG versus standard of care for reducing odor and treating malodorous recalcitrant wounds.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wounds and Injuries

Drugs mentioned

• PRP-FG
• Supraz

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Wounds and Injuries | Phase 2, Phase 3 | Status: UNKNOWN